Filter

1 - 10 of 72 Results

  • COVAX and the United States

    Issue Brief

    This issue brief provides an overview of COVAX, the global mechanism to secure and deliver COVID-19 vaccines. The brief details COVAX's organization, conditions for country participation, activities, and financing structure. Additionally, it looks at the history and remaining key issues of U.S. engagement with COVAX.

  • Assessing the Role of Treaties, Conventions, Institutions, and Other International Agreements in the Global COVID-19 Response: Implications for the Future

    Issue Brief

    This issue brief examines existing treaties and other global health agreements to assess whether they have been utilized for the COVID-19 pandemic response and whether they contain pandemic preparedness and response components in their mandates. The COVID-19 pandemic challenged and revealed gaps in global health governance systems, prompting stakeholders to reevaluate existing frameworks and discuss new agreements aimed at addressing future pandemics. To help inform these discussions, we evaluate existing global health agreements to assess their role in pandemic preparedness and response efforts, including the COVID-19 pandemic.

  • The U.S. Government and Global Health Security

    Issue Brief

    This brief examines the U.S. government's efforts in global health security—that is, activities to help countries prepare for and develop capacities to address epidemic and pandemic diseases. It provides history and background, outlines the U.S. agencies carrying out these efforts, describes funding, and highlights key policy issues going forward.

  • Global COVID-19 Vaccine Equity: U.S. Policy Options and Actions to Date

    Issue Brief

    This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.

  • Global COVID-19 Vaccine Access: A Snapshot of Inequality

    Policy Watch

    This policy watch examines global access to COVID-19 vaccines by country income level, assessing country income levels' shares of purchased doses and potential vaccination coverage, while also looking closely at the potential impact of COVAX in addressing vaccine access disparity between high-income and low- and middle-income countries.

  • The ‘Pandemic Agreement’: What it is, What it isn’t, and What it Could Mean for the U.S.

    Issue Brief

    Countries are seeking to create a new 'pandemic agreement' at WHO to strengthen pandemic prevention, preparedness, and response. This brief explains what the pandemic agreement is, where the U.S. stands on issues included in the agreement, and potential outcomes of the ongoing negotiations. It also evaluates several criticisms of the agreement and the evidence for each.

  • The U.S. Government and Gavi, the Vaccine Alliance

    Fact Sheet

    This fact sheet examines Gavi, the Vaccine Alliance (also known as Gavi), an independent, public-private partnership and multilateral funding mechanism that aims to increase access to immunization in lower income countries, and explores the role the U.S. government plays in supporting the partnership.

  • U.S. Global Health Budget Tracker

    Feature

    This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels for U.S. global health efforts through bilateral and multilateral contributions and by program area and agency.

  • The New Pandemic Fund: Overview and Key Issues for the U.S.

    Issue Brief

    This brief offers an overview of the new multilateral global health financing mechanism known as the Pandemic Fund, which is housed at the World Bank. The brief reviews the evolution of the Fund, its current financial status and donors, U.S. engagement, and policy issues going forward.